RegeNeron.com
Title
Regeneron
Description
Regeneron has several product candidates progressing through all stages of human clinical trials, for the potential treatment of a diverse set of diseases, including cancer, eye diseases, and inflammation.
Regeneron is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical conditions. Regeneron has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammation. The Company also has preclinical programs in asthma, allergies, and other diseases and disorders. Regeneron has developed several proprietary platform technologies, which it has incorporated into a comprehensive discovery and development process designed to understand thoroughly the biology of specific disease states, discover potential therapeutic candidates, and evaluate these candidates in clinical trials.
Regeneron Pharmaceuticals was founded in 1988 by Chief Executive Officer Leonard S. Schleifer, M.D., Ph.D., to develop and commercialize new therapeutic agents to treat unmet medical needs. The founding principle was that strong science would lead to potentially important new therapeutic opportunities, and the Company was initially focused on treatments for diseases of the nervous system. When P. Roy Vagelos, M.D., former Chairman and CEO of Merck & Co., Inc, joined Regeneron as its Chairman in 1995, he encouraged development of the Company's strength in science and technology in more diverse disease settings, such as in cancer, eye diseases, and inflammation.
Contact
| Whois information is public, but in response to some people wanting to keep their contact information private, many domain name Registrars offer a "privacy" or "proxy" service to mask the domain name owner. This domain is most likely using a proxy service. |
Additional Information
Related Domains
- 13 Trap
- 1 Trap
- Appetite
- Appetite Control
- Appetite Loss
- Appetite Suppression
- Biology
- Cntf
- Ciliary Neurotrophic Factor
- Clinical Trial
- Clinical Trials
- Cytokines
- Diet
- Diet Drug
- Diet Medicine
- Drug For Appetite Suppression
- Drug For Weight Loss
- Fat
- Fat Drug
- Fat Medicine
- Il
- Il1
- Il13 Trap
- Il1 Trap
- Il4 Trap
- Immunology
- Investigatory Drug
- Investigatory Drugs
- Medicine For Weight Loss
- Morbid Obesity
- Morbidly Obese
- New Medicine
- Obese
- Obesity
- Obesity Drug
- Obesity Drug Development
- Obesity Medicine
- Obesity Product
- Overweight
- Product Candidate
- Product Candidates
- Products And Services
- Regn
- Regeneron
- Regeneron Pharmaceuticals
- Satiety
- Satiety Center
- Science
- Therapeutic Product
- Therapeutic Product Candidate
- Therapeutic Product Candidates
- Trap
- Traps
- Vegf
- Vegf Trap
- Weight Loss
- Weight Loss Clinical Trial
- Weight Loss Drug
- Weight Loss Medicine
- 1
- CNTF
- IL
- IL1
- IL13 Trap
- IL1 Trap
- IL4 Trap
- Products and Services
- REGN
- VEGF
- VEGF Trap